Cholelithiasis in Children with Sickle Cell Disease in Ouagadougou Pediatric Hospital


Introduction: Sickle cell disease (SCD) causes chronic hemolysis which is a risk factor for cholelithiasis. Its development may lead to severe and life-threatening complications. Objective: Determine the prevalence of cholelithiasis, the conditions of diagnosis and related factors. Materials and Method: We retrospectively reviewed records of 110 patients with sickle cell disease followed up in Charles de Gaulle University Pediatric Hospital from January 2003 to December 2013, including 103 patients who had abdominal ultrasonography. Results: Cholelithiasis prevalence was 24.3%. The mean age of patients was 10.8 years, (range 3 to 15 years). Sex ratio was 2.1. In 88% cases, cholelithiasis was diagnosed based on the characteristic symptoms of right hypocondrial pain, fever and icterus. Most factors associated with cholelithiasis were as follows: age above 10 years (OR = 4), occurrence of at least three (03) vaso-occlusive crises per year (OR = 7.6), history of blood transfusion (OR = 8), right hypochondrial pain (OR = 4.5) and icterus (OR = 15). Only 20% of patients suffering from a symptomatic cholelithiasis underwent laparoscopic cholecystectomy and results were conclusive. Conclusion: Patients with sickle cell disease, especially those aged above 10, should be routinely tested for cholelithiasis using abdominal ultrasonography at least once a year. Because of the difficulties in managing evolutive complications in case of an emergency in our context, we advocate laparoscopic cholecystectomy of any cholelithiasisas soon as it is diagnosed in children with sickle cell disease.

Share and Cite:

Kouéta, F. , Kaboret, S. , Yonaba, C. , Kaboré, A. , Dao, L. , Daïla, S. , Savadogo, H. , Bandré, E. and Yé, D. (2015) Cholelithiasis in Children with Sickle Cell Disease in Ouagadougou Pediatric Hospital. Open Journal of Pediatrics, 5, 256-262. doi: 10.4236/ojped.2015.53039.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Attalla, B.A.I., Karrar, Z.A., Ibnouf, G., Mohamed, A.O., Abdelwahab, O., Nasir, E.M., et al. (2013) Outcome of cholelithiasis in Sudanese children with Sickle Cell Anaemia (SCA) after 13 Years Follow-Up. African Health Sciences, 13, 154-159.
[2] Diagne, I., Badiane, M., Moreira, C., Signaté-Sy, H., Ndiaye, O., Lopez-Sail, P., et al. (1999) Lithiase biliaire et drépanocytose homozygote en pédiatrie à Dakar (Sénégal). Archives de Pédiatrie, 6, 1286-1292.
[3] Parez, N., Quinet, B., Batut, S., Grimprel, E., Larroquet, M., Audry, G., et al. (2001) Lithiase biliaire chez l’enfant drépanocytaire: Expérience d’un hopital pédiatrique parisien. Archives de Pédiatrie, 8, 1045-1049.
[4] Everson, G.T., Nemeth, A., Kourourian, S., Zogy, D., Leff, N.B., Dixon D., et al. (1989) Gallbladder Function Is Altered in Sickle Haemoglobinopathy. Gastroenterology, 96, 1307-1316.
[5] Akinyanju, O. and Ladapo, F. (1979) Cholelithiasis and Biliary Tract Disease in Sickle Cell Disease in Nigerians. Postgraduate Medical Journal, 55, 400-402.
[6] Dos Santos, G.A.P., Bellomo-Brandao, M.A. and Da Costa-Pinto, E.A.L. (2008) Gallstones in Children with Sickle Cell Disease Followed up at a Brazilian Hematology Center. Arquivos de Gastroenterologia, 45, 313-318.
[7] Serjeant, B.R. and Serjeant, B.E. (1993) Management of Sickle Cell Disease; Lessons of Jamaican Cohort Study. Blood Reviews, 7, 137-145.
[8] Yé, D., Kouéta F., Dao, L., Kaboret, S. and Sawadogo, A. (2008) Prise en charge de la drépanocytose en milieu pédiatrique: Expérience du centre hospitalier universitaire pédiatrique Charles-de-Gaulle de Ouagadougou (Burkina Faso). Santé, 18, 70-75.
[9] Athanassiou-Metaxa, M., Tsatra, I. and Koussi, A. (2002) Lithiase biliaire chez les patients drépanocytaires: L’expérience grecque. Archives de Pédiatrie, 8, 878.
[10] Silva, I.V., Reis, A.F., Palare, M.J., Ferrao, A., Rodrigues, T. and Morais, A. (2015) Sickle Cell Disease in Children: Chronic Complications and Search of Predictive Factors for Adverse Outcomes. European Journal of Haematology, 94, 157-161.
[11] Itoua-Ngaporo, A., Ngoma, K. and Paris, J.C. (1987) La prevalence de la lithiase biliaire dans la drépanocytose homozygote. Médecine et Chirurgie Digestives, 16, 479-482.
[12] Abby, C.B., Sangaré, A., Bougouma, A., Méité, M., Kéita, A., Djédjé, A.T., et al. (1996) Lithiase biliaire et drépanocytose. Rev Méd Cote-d’Ivoire, 78, 27-31.
[13] Sarnaik, S., Slovis, T.L., Corbett, D.P., Emami, A. and Whitten, C.F. (1980) Incidence of Cholelithiasis in Sickle Cell Anemia Using the Ultrasonic Gray-Scale Technique. The Journal of Pediatrics, 96, 1005-1008.
[14] Bond, L.R., Hatty, S.R., Horn, M.E.C., Dick, M., Meire, H.B. and Bellingham, A.J.G. (1987) Stones in Sickle Cell Disease in the United Kingdom. BMJ, 295, 234-236.
[15] Bogue, C.O., Murphy, A.J., Gerstle, J.T., Moineddin, R. and Daneman, A. (2010) Risk Factors, Complications, and Outcomes of Gallstones in Children: A Singlecenter Review. Journal of Pediatric Gastroenterology & Nutrition, 50, 303-308.
[16] Nzeh, D.A. and Adedoyin, M.A. (1989) Sonographic Pattern of Gallbladder Disease in Children with Sickle Cell Anaemia. Pediatric Radiology, 19, 290-292.
[17] Werlin, S.L. and Scott, J.P. (1996) Is Biliary Sludge a Stone-in-Waiting? The Journal of Pediatrics, 129, 321-322.
[18] Durosinmi, M.A., Ogunseyinde, A.O., Olatunji, P.O. and Esnas, J.F. (1989) Prevalence of Cholelithiasis in Nigerians with Sickle-Cell Disease. African Journal of Medical Sciences, 18, 223-227.
[19] Stephens, C.G. and Scott, R.B. (1980) Cholelithiasis in Sickle Cell Anaemia: Surgical or Medical Management. Archives of Internal Medicine, 140, 648-651.
[20] Malone, B.S. and Werlin, S.L. (1988) Cholecystectomy and Cholelithiasis in Sickle Cell Anaemia. American Journal of Diseases of Children, 142, 799-800.
[21] Diop, N., Diao-Bah, M., Ndiaye-Pape, L., Diouf, E., Kane, O., Bèye, M., et al. (2008) Priseen charge peri-operatoire de la cholecystectomie par voielaparoscopique chez l’enfantdrépanocytaire homozygote. Archives de Pédiatrie, 15, 1393-1397.

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.